Notable Labs
Personalized drug discovery for blood cancer.
San Francisco
40 employees
Diagnostics
Growth · $72.2M
About Notable Labs
Personalized drug discovery for blood cancer.
Personalized drug discovery for blood cancer.
Personalized drug discovery for blood cancer.
Total raised
$72.2M
Last stage
Growth
Investors
Matthew De Silva
Co-founded Notable Labs in 2014 after his father was diagnosed with brain cancer and faced a lack of effective treatment options. Previously a hedge fund manager before pivoting to biotech.
LinkedIn
Peter Quinzio
Co-founded Notable Labs in 2014 alongside Matthew De Silva. Previously served as CTO and Scientific Founder at Notable Labs.
LinkedInNo applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.